Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SOLENO THERAPEUTICS INC (SLNO)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Net income | -8.5 | -8.4 | -5.5 | -6.1 | -6.7 | -5.7 | -2.8 | -8.1 |
| Depreciation and amortization [+] | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Depreciation | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Stock-based compensation | | | | -1.2 | | | | -2.0 |
| Change in working capital [+] | 0.3 | -0.7 | 5.9 | 1.1 | 0.4 | -0.1 | 8.5 | 0.5 |
| Other current assets | | | | -0.3 | | | | -0.1 |
| Accounts payable | | | | 0.8 | | | | 0.2 |
| Other | 0.3 | -0.7 | 5.9 | 0.6 | 0.4 | -0.1 | 8.5 | 0.4 |
| Other operating activities | 2.2 | 1.9 | -6.1 | 1.1 | 1.2 | -1.0 | -13.0 | 3.7 |
| Cash from operations | -5.6 | -6.7 | -5.1 | -4.7 | -4.6 | -6.4 | -6.9 | -5.4 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Purchases of property and equipment | | | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
| Other cash from investing | | | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
| Cash from investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Other cash from financing | 17.1 | | | 0.3 | -0.3 | 14.0 | 0.0 | |
| Cash from financing | 17.1 | 0.0 | 0.0 | 0.3 | -0.3 | 14.0 | 0.0 | 0.0 |
| |
| Free cash flow | -5.6 | -6.7 | -5.1 | -4.6 | -4.6 | -6.4 | -6.9 | -5.4 |
| Per share (diluted) | ($0.53) | ($0.71) | ($0.61) | ($0.57) | ($0.49) | ($1.19) | ($1.29) | ($1.01) |
|